Related references
Note: Only part of the references are listed.Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial
Geltrude Mingrone et al.
LANCET (2021)
Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling
Yixuan Qiu et al.
ANNALS OF MEDICINE (2021)
The Unconventional Role for Gastric Volume in the Response to Bariatric Surgery for Both Weight Loss and Glucose Lowering
Simon S. Evers et al.
ANNALS OF SURGERY (2020)
NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis
Stephen A. Harrison et al.
HEPATOLOGY (2020)
Bile acid treatment and FXR agonism lower postprandial lipemia in mice
Sarah Farr et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)
Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible
Albert Kolomansky et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Assessment of the role of FGF15 in mediating the metabolic outcomes of murine vertical sleeve gastrectomy
Andriy Myronovych et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)
The Role of Elevated Branched-Chain Amino Acids in the Effects of Vertical Sleeve Gastrectomy to Reduce Weight and Improve Glucose Regulation
Nadejda Bozadjieva Kramer et al.
CELL REPORTS (2020)
FGF19 Analog as a Surgical Factor Mimetic That Contributes to Metabolic Effects Beyond Glucose Homeostasis
Alex M. DePaoli et al.
DIABETES (2019)
Fibroblast growth factor 21 controls mitophagy and muscle mass
Lynette J. Oost et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
G-CSF partially mediates effects of sleeve gastrectomy on the bone marrow niche
Ziru Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia
Christopher M. Mulla et al.
OBESITY SURGERY (2019)
FGF21 as Modulator of Metabolism in Health and Disease
Caterina Tezze et al.
FRONTIERS IN PHYSIOLOGY (2019)
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
Evan Bolyen et al.
NATURE BIOTECHNOLOGY (2019)
Weight Loss and Changes in Adipose Tissue and Skeletal Muscle Volume after Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: a Prospective Study with 12-Month Follow-Up
Hannes Goetz Kenngott et al.
OBESITY SURGERY (2019)
Elevated FGF23 and disordered renal mineral handling with reduced bone mineralization in chronically erythropoietin over-expressing transgenic mice
Arezoo Daryadel et al.
SCIENTIFIC REPORTS (2019)
Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery
Vance L. Albaugh et al.
GASTROENTEROLOGY (2019)
Glycemic effect of pancreatic preproglucagon in mouse sleeve gastrectomy
Ki-Suk Kim et al.
JCI INSIGHT (2019)
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
Na Jiao et al.
GUT (2018)
Review article: therapeutic bile acids and the risks for hepatotoxicity
K. Ashby et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Heart and bile acids - Clinical consequences of altered bile acid metabolism
Tharni Vasavan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Diet1, bile acid diarrhea, and FGF15/19: mouse model and human genetic variants
Jessica M. Lee et al.
JOURNAL OF LIPID RESEARCH (2018)
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen A. Harrison et al.
LANCET (2018)
Bile Acid Sequestration by Cholestyramine Mitigates FGFR4 Inhibition-Induced ALT Elevation
Heiko S. Schadt et al.
TOXICOLOGICAL SCIENCES (2018)
Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2′s q2-feature-classifier plugin
Nicholas A. Bokulich et al.
MICROBIOME (2018)
GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr-/- mice and is dispensable for the metabolic benefits ensuing after vertical sleeve gastrectomy
Anita Patel et al.
MOLECULAR METABOLISM (2018)
Targeting FXR and FGF19 to Treat Metabolic DiseasesLessons Learned From Bariatric Surgery
Nadejda Bozadjieva et al.
DIABETES (2018)
Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives
Emmanuel Somm et al.
ENDOCRINE REVIEWS (2018)
Metabolic comparison of one-anastomosis gastric bypass, single-anastomosis duodenal-switch, Roux-en-Y gastric bypass, and vertical sleeve gastrectomy in rate
Deanna M. Arble et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2018)
Bile Acid Excess Induces Cardiomyopathy and Metabolic Dysfunctions in the Heart
Moreshwar S. Desai et al.
HEPATOLOGY (2017)
The Effects of Bariatric Surgery on Bone Metabolism
Naina Sinha Gregory
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2017)
Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow
Erica L. Clinkenbeard et al.
HAEMATOLOGICA (2017)
Effect of Lactobacillus on body weight and body fat in overweight subjects: a systematic review of randomized controlled clinical trials
L. Crovesy et al.
INTERNATIONAL JOURNAL OF OBESITY (2017)
Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice
Berengere Benoit et al.
NATURE MEDICINE (2017)
Bariatric Surgery versus Intensive Medical Therapy for Diabetes-5-Year Outcomes
Philip R. Schauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Weight and Metabolic Outcomes 12 Years after Gastric Bypass
Ted D. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Surgically Induced Changes in Gut Microbiome and Hedonic Eating as Related to Weight Loss: Preliminary Findings in Obese Women Undergoing Bariatric Surgery
Claudia P. Sanmiguel et al.
PSYCHOSOMATIC MEDICINE (2017)
Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow
Erica L. Clinkenbeard et al.
HAEMATOLOGICA (2017)
FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia
Tian Lan et al.
CELL METABOLISM (2017)
FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss
Javier Gomez-Ambrosi et al.
CLINICAL NUTRITION (2017)
FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes
Saachi Sachdev et al.
OBESITY SURGERY (2016)
Changes in Bile Acid Profile After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Metabolic Profile and Fatty Liver Disease
Ajay P. Belgaumkar et al.
OBESITY SURGERY (2016)
Insulin Resistance, Microbiota, and Fat Distribution Changes by a New Model of Vertical Sleeve Gastrectomy in Obese Rats
Nicola Basso et al.
DIABETES (2016)
Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes
David P. Sonne et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Fibroblast Growth Factor 21 Correlates with Weight Loss After Vertical Sleeve Gastrectomy in Adolescents
Farooq H. Khan et al.
Obesity (2016)
New therapeutic approaches for the treatment of obesity
Alan R. Saltiel
SCIENCE TRANSLATIONAL MEDICINE (2016)
A Genetic Screen Identifies Hypothalamic Fgf15 as a Regulator of Glucagon Secretion
Alexandre Picard et al.
CELL REPORTS (2016)
Low protein diets produce divergent effects on energy balance
Adel Pezeshki et al.
SCIENTIFIC REPORTS (2016)
Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein-Coupled Bile Acid Receptors
Cheryl A. Brighton et al.
ENDOCRINOLOGY (2015)
Erythropoietin directly stimulates osteoclast precursors and induces bone loss
Sahar Hiram-Bab et al.
FASEB JOURNAL (2015)
Fecal Microbiota Transplantation Eliminates Clostridium difficile in a Murine Model of Relapsing Disease
Anna M. Seekatz et al.
INFECTION AND IMMUNITY (2015)
Improvements in Glucose Metabolism Early After Gastric Bypass Surgery Are Not Explained by Increases in Total Bile Acids and Fibroblast Growth Factor 19 Concentrations
Nils B. Jorgensen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
FGF21 and the late adaptive response to starvation in humans
Pouneh K. Fazeli et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Metabolic bone changes after bariatric surgery
Julie Kim et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2015)
Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues
Erica L. Scheller et al.
NATURE COMMUNICATIONS (2015)
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
Changtao Jiang et al.
NATURE COMMUNICATIONS (2015)
Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress
Seong Hun Kim et al.
DIABETOLOGIA (2015)
Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients
J. M. Gallego-Escuredo et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
FGF-21 and Skeletal Remodeling During and After Lactation in C57BL/6J Mice
Sheila Bornstein et al.
ENDOCRINOLOGY (2014)
Carbohydrate Feeding Dissociates the Postprandial FGF19 Response From Circulating Bile Acid Levels in Humans
Gregory J. Morton et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
FXR is a molecular target for the effects of vertical sleeve gastrectomy
Karen K. Ryan et al.
NATURE (2014)
Vertical Sleeve Gastrectomy Reduces Hepatic Steatosis While Increasing Serum Bile Acids in a Weight-Loss-Independent Manner
Andriy Myronovych et al.
OBESITY (2014)
Bone loss after bariatric surgery: causes, consequences, and management
Emily M. Stein et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individuals
Olga Renner et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2014)
Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice
Matthew J. Potthoff et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform
James J. Kozich et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2013)
Overnutrition Stimulates Intestinal Epithelium Proliferation Through β-Catenin Signaling in Obese Mice
Jiaming Mao et al.
DIABETES (2013)
Fibroblast Growth Factor-19 Action in the Brain Reduces Food Intake and Body Weight and Improves Glucose Tolerance in Male Rats
Karen K. Ryan et al.
ENDOCRINOLOGY (2013)
Are Bile Acids the New Gut Hormones? Lessons From Weight Loss Surgery Models
D. J. Pournaras et al.
ENDOCRINOLOGY (2013)
FGF19 action in the brain induces insulin-independent glucose lowering
Gregory J. Morton et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Laparoscopic Sleeve Gastrectomy Differentially Affects Serum Concentrations of FGF-19 and FGF-21 in Morbidly Obese Subjects
D. Haluzikova et al.
OBESITY (2013)
Loss of Function of the Melanocortin 2 Receptor Accessory Protein 2 Is Associated with Mammalian Obesity
Masato Asai et al.
SCIENCE (2013)
Conserved Shifts in the Gut Microbiota Due to Gastric Bypass Reduce Host Weight and Adiposity
Alice P. Liou et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity
Fei Li et al.
NATURE COMMUNICATIONS (2013)
Circulating Fibroblast Growth Factors as Metabolic Regulators-A Critical Appraisal
Bo Angelin et al.
CELL METABOLISM (2012)
Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease
Fatih Eren et al.
CLINICAL BIOCHEMISTRY (2012)
The Role of Bile After Roux-en-Y Gastric Bypass in Promoting Weight Loss and Improving Glycaemic Control
Dimitri J. Pournaras et al.
ENDOCRINOLOGY (2012)
An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea
Daniel McDonald et al.
ISME JOURNAL (2012)
Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ
Wei Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Fibroblast Growth Factor 19 Treatment Ameliorates Disruption of Hepatic Lipid Metabolism in Farnesoid X Receptor (Fxr)-Null Mice
Masaaki Miyata et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α Pathway
Matthew J. Potthoff et al.
CELL METABOLISM (2011)
Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
Janne Prawitt et al.
DIABETES (2011)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
A New Model for Portal Protein Profile Analysis in Course of Ileal Intraluminal Bile Acid Infusion Using an In Situ Perfused Rat Intestine
Marco Montagnani et al.
MEDICINAL CHEMISTRY (2011)
FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
Serkan Kir et al.
SCIENCE (2011)
Metagenomic biomarker discovery and explanation
Nicola Segata et al.
GENOME BIOLOGY (2011)
Serum Concentrations of Fibroblast Growth Factor 19 in Patients With Obesity and Type 2 Diabetes Mellitus: the Influence of Acute Hyperinsulinemia, Very-Low Calorie Diet and PPAR-alpha Agonist Treatment
M. Mraz et al.
PHYSIOLOGICAL RESEARCH (2011)
Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities
Rohit Kohli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
Jody Dushay et al.
GASTROENTEROLOGY (2010)
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
Huating Li et al.
JOURNAL OF HEPATOLOGY (2010)
Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse
Klementina Fon Tacer et al.
MOLECULAR ENDOCRINOLOGY (2010)
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Charles Thomas et al.
CELL METABOLISM (2009)
Bile acids: analysis in biological fluids and tissues
William J. Griffiths et al.
JOURNAL OF LIPID RESEARCH (2009)
Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism
Mary-Elizabeth Patti et al.
OBESITY (2009)
Bile-acid-induced cell injury and protection
Maria J. Perez et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
Xinmei Zhang et al.
DIABETES (2008)
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
Jerry M. Wells et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
Insook Kim et al.
JOURNAL OF LIPID RESEARCH (2007)
Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states
Michael K. Badman et al.
CELL METABOLISM (2007)
Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21
Takeshi Inagaki et al.
CELL METABOLISM (2007)
Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities
Catherine A. Lozupone et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1
S Katsuma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Fibroblast growth factor 19 increases metabolic rate I and reverses dietary and leptlin-deficient diabetes
L Fu et al.
ENDOCRINOLOGY (2004)
Study of Fgf15 gene expression in developing mouse brain
L Gimeno et al.
GENE EXPRESSION PATTERNS (2003)
Analysis of Fgf15 expression pattern in the mouse neural tube
L Gimeno et al.
BRAIN RESEARCH BULLETIN (2002)
One or more labile proteins regulate the stability of chimeric mRNA containing the 3′-untranslated region of cholesterol-7α-hydroxylase mRNA
DM Baker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
